Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01478178
Title Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors DelMar Pharmaceuticals, Inc.
Indications

high grade glioma

glioblastoma

Therapies

VAL-083

Age Groups: adult
Covered Countries USA


No variant requirements are available.